Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.54
-0.08 (-1.11%)
At close: Sep 05, 2025, 3:59 PM
7.35
-2.52%
After-hours: Sep 05, 2025, 04:10 PM EDT
-1.11% (1D)
| Bid | 7.35 |
| Market Cap | 4.43M |
| Revenue (ttm) | 100.37K |
| Net Income (ttm) | -12.17M |
| EPS (ttm) | 958.65 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.48 |
| Analyst | n/a |
| Ask | 7.72 |
| Volume | 1,493 |
| Avg. Volume (20D) | 5,495 |
| Open | 7.79 |
| Previous Close | 7.62 |
| Day's Range | 7.40 - 7.79 |
| 52-Week Range | 5.01 - 54.95 |
| Beta | 1.82 |
About QNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
3 months ago
+0%
QNRX stock has given up its prior gain. Quoin Phar...
Unlock content with
Pro Subscription
3 months ago
+0%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.
